Tigecycline-induced Coagulation Gene Prognostic Prediction Model and Intestinal Flora Signature in AML

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Nov 29

PMID 39611150

Authors

Feng-Luan Zhong

Jia-Jun He

Kun-Hao Bai

Ruo-Nan Shao

Guo-Yan Wu

Xiao-Peng Tian

Da-Wei Wang

Yu-Jun Dai

Si-Liang Chen

Affiliations

Soon will be listed here.

Abstract

Infection is among the most common causes of death in patients with acute myeloid leukemia (AML) after chemotherapy. The anti-tumor effect of the intestinal microbiota in patients with AML is increasingly being recognized. Tigecycline, a broad-spectrum antibiotics, plays a vital role in the anti-infection treatment of AML patients with neutropenia and accompanying infections. Previously, this group reported that long-term use of tigecycline caused coagulation dysfunction in patients with hematological malignancies, increasing the risk of casualties. RNA sequencing was performed on CHO cells before and after tigecycline treatment. Further, the combined analysis of AML prognostic differentially expressed genes revealed 13 genes affected by tigecycline and closely related to AML prognosis. These genes were used for modeling analysis, and the results showed that the prepared model significantly improved the prognostic prediction efficiency for AML patients. The model also explored the correlation between prognosis score and immune cells infiltrating tumors and immune therapy targets. Moreover, 16S sequencing was performed on fecal samples from AML patients before and after tigecycline treatment. The results revealed that tigecycline significantly altered the distribution of intestinal microbiota in AML patients - These changes in microbiota are related to chemotherapy resistance. This study emphasizes the importance of intestinal microbiota in AML prognosis. Thus, the findings of this study show that the long-term use of antibiotics can not only cause dysbiosis of the intestinal microbiota but also indirectly affect the sensitivity of chemotherapy drugs, affecting the prognosis of AML patients.

References

Skrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z . Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2011; 20(5):674-88. PMC: 3221282. DOI: 10.1016/j.ccr.2011.10.015. View

Shih Y, Wang M, Monsen K, Chang C, Andy Rias Y, Tsai H . Effectiveness of Acupuncture for Relieving Chemotherapy-Induced Bone Marrow Suppression: A Systematic Review with a Meta-analysis and Trial Sequential Analysis. J Integr Complement Med. 2023; 29(10):621-636. DOI: 10.1089/jicm.2022.0735. View

Chen S, Liu S, Chen F, Wang C, Mai H, Yuan X . [Changes of intestinal flora in children with acute lymphoblastic leukemia before and after chemotherapy]. Zhongguo Dang Dai Er Ke Za Zhi. 2022; 24(5):550-560. PMC: 9154360. DOI: 10.7499/j.issn.1008-8830.2110045. View

Mu H, Nourian M, Jiang H, Tran J, Cole B . Mycoplasma superantigen initiates a TLR4-dependent Th17 cascade that enhances arthritis after blocking B7-1 in Mycoplasma arthritidis-infected mice. Cell Microbiol. 2013; 16(6):896-911. DOI: 10.1111/cmi.12247. View

Jiang Y, He J, Wang X, Liu C, Zhou W, Liu D . Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis. Platelets. 2023; 34(1):2212071. DOI: 10.1080/09537104.2023.2212071. View

Kuntz E, Baquero P, Michie A, Dunn K, Tardito S, Holyoake T . Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med. 2017; 23(10):1234-1240. PMC: 5657469. DOI: 10.1038/nm.4399. View

Moore J, Mistry J, Hellmich C, Horton R, Wojtowicz E, Jibril A . LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation. J Clin Invest. 2022; 132(5). PMC: 8884913. DOI: 10.1172/JCI153157. View

Smith M, Dai A, Ghilardi G, Amelsberg K, Devlin S, Pajarillo R . Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med. 2022; 28(4):713-723. PMC: 9434490. DOI: 10.1038/s41591-022-01702-9. View

Provinciali M, Cirioni O, Orlando F, Pierpaoli E, Barucca A, Silvestri C . Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. J Med Microbiol. 2011; 60(Pt 12):1806-1812. DOI: 10.1099/jmm.0.032516-0. View

10.

Guo M, Liu H, Yu Y, Zhu X, Xie H, Wei C . GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure. Gut Microbes. 2023; 15(1):2190304. PMC: 10038048. DOI: 10.1080/19490976.2023.2190304. View

11.

Xie J, Zou Y, Ye F, Zhao W, Xie X, Ou X . A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer. Front Cell Dev Biol. 2022; 9:795600. PMC: 8790231. DOI: 10.3389/fcell.2021.795600. View

12.

Tran T, Vo T, Lam L, Le N . ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: Comprehensive multi-omics analysis. Comput Struct Biotechnol J. 2023; 21:1921-1929. PMC: 10018390. DOI: 10.1016/j.csbj.2023.02.045. View

13.

Nikitin A . [Tigecycline: antimicrobial action, chemotherapeutic efficacy and adverse reactions]. Antibiot Khimioter. 2009; 54(1-2):63-6. View

14.

Yaghoubi S, Zekiy A, Krutova M, Gholami M, Kouhsari E, Sholeh M . Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2021; 41(7):1003-1022. PMC: 7785128. DOI: 10.1007/s10096-020-04121-1. View

15.

Wang D, Lin C, Gu C, Wu Y, Wang S . Tigecycline-Associated Coagulopathy: A Single-Center Retrospective Analysis. Pharmacology. 2022; 107(9-10):524-536. DOI: 10.1159/000525380. View

16.

Elgazzar D, Aboubakr M, Bayoumi H, Ibrahim A, Sorour S, El-Hewaity M . Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay. Pharmaceuticals (Basel). 2022; 15(6). PMC: 9228782. DOI: 10.3390/ph15060736. View

17.

Wang R, Yang X, Liu J, Zhong F, Zhang C, Chen Y . Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022; 13(1):2522. PMC: 9085760. DOI: 10.1038/s41467-022-30240-8. View

18.

Dang H, Ta H, Nguyen T, Anuraga G, Wang C, Lee K . Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation. Funct Integr Genomics. 2022; 22(5):1057-1072. DOI: 10.1007/s10142-022-00883-3. View

19.

Liu Y, Yang M, Tang L, Wang F, Huang S, Liu S . TLR4 regulates RORγt regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila. Microbiome. 2022; 10(1):98. PMC: 9235089. DOI: 10.1186/s40168-022-01296-x. View

20.

Sun L, Bai K, Wu G, Tian X, Zou Z, Wang D . Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients. Front Pharmacol. 2022; 13:891952. PMC: 9294380. DOI: 10.3389/fphar.2022.891952. View